Mitochondrial respiratory chain complex II

Mitochondrial Disorders Caused by Nuclear Genes

Volumn , Issue , 2014, Pages 203-218

  Ganesh, Jaya ^a   Wong, Lee Jun C ^b   Gorman, Elizabeth B ^b  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Cardiomyopathy; Complex II; Leigh syndrome; Paraganglioma; SDH; Succinate dehydrogenase; Tumorigenesis

Indexed keywords

EID: 84929535164     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4614-3722-2_13     Document Type: Chapter

References (54)

1. Sun F et al (2005) Crystal structure of mitochondrial respiratory membrane protein complex II. Cell 121(7):1043-1057
2. Lancaster CR (2002) Succinate:Quinone oxidoreductases: an overview. Biochim Biophys Acta 1553(1-2):1-6
3. Rutter JWinge DR, Schiffman JD (2010) Succinate dehydrogenase-assembly, regulation and role in human disease. Mitochondrion 10(4):393-401
4. Robinson KM et al (1994) The covalent attachment of FAD to the flavoprotein of Saccharomyces cerevisiae succinate dehydrogenase is not necessary for import and assembly into mitochondria. Eur J Biochem 222(3):983-990
5. Rustin P, RotigA (2002) Inborn errors of complex II-unusual human mitochondrial diseases. Biochim Biophys Acta 1553(1-2):117-22
6. Schafer G, Anemuller S, Moll R (2002) Archaeal complex II: 'Classical' and 'non-classical' succinate:quinone reductases with unusual features. Biochim Biophys Acta 1553(1-2):57-73
7. Ghezzi D et al (2009) SDHAF1, encoding a LYR complex-II specific assembly factor, is mutated in SDH-defective infantile leukoencephalopathy. Nat Genet 41(6):654-656
8. Hao HX et al (2009) SDH5, a gene required for flavination of succinate dehydrogenase, is mutated in paraganglioma. Science 325(5944):1139-1142
9. Sucheta A et al (1992) Diode-like behaviour of a mitochondrial electron-transport enzyme. Nature 356(6367):361-362
10. Yankovskaya V et al (2003) Architecture of succinate dehydrogenase and reactive oxygen species generation. Science 299(5607):700-704
11. Finsterer J (2008) Leigh and Leigh-like syndrome in children and adults. Pediatr Neurol 39(4):223-235
12. Guzy RD et al (2008) Loss of the SdhB, but not the SdhA, subunit of complex II triggers reactive oxygen species-dependent hypoxia-inducible factor activation and tumorigenesis. Mol Cell Biol 28(2):718-731.
13. Rivner MH et al (1989) Kearns-Sayre syndrome and complex II deficiency. Neurology 39(5):693-696
14. Reichmann H, Angelini C (1994) Single muscle fibre analyses in 2 brothers with succinate dehydrogenase deficiency. Eur Neurol 34(2):95-98
15. Bourgeron T et al (1995) Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency. Nat Genet 11(2):144-149
16. Parfait B et al (2000) Compound heterozygous mutations in the flavoprotein gene of the respiratory chain complex II in a patient with Leigh syndrome. Hum Genet 106(2):236-243
17. Van Coster R et al (2003) Homozygous Gly555Glu mutation in the nuclear-encoded 70 kDa flavoprotein gene causes instability of the respiratory chain complex II. Am J Med Genet A 120A(1):13-18
18. Horvath R et al (2006) Leigh syndrome caused by mutations in the flavoprotein (Fp) subunit of succinate dehydrogenase (SDHA). J Neurol Neurosurg Psychiatry 77(1):74-76
19. Taylor RW et al (1996) Deficiency of complex II of the mitochondrial respiratory chain in late-onset optic atrophy and ataxia. Ann Neurol 39(2):224-232
20. Birch-Machin MA et al (2000) Late-onset optic atrophy, ataxia, and myopathy associated with a mutation of a complex II gene. Ann Neurol 48(3):330-335
21. Bugiani M et al (2006) Effects of riboflavin in children with complex II deficiency. Brain Dev 28(9):576-581
22. Brockmann K et al (2002) Succinate in dystrophic white matter: a proton magnetic resonance spectroscopy finding characteristic for complex II deficiency. Ann Neurol 52(1):38-46
23. Saneto RP, Friedman SD, Shaw DW (2008) Neuroimaging of mitochondrial disease. Mitochondrion 8(5-6):396-413
24. Moroni I et al (2002) Cerebral white matter involvement in children with mitochondrial encephalopathies. Neuropediatrics 33(2):79-85
25. Pasini B , Stratakis CA (2009) SDH mutations in tumorigenesis and inherited endocrine tumours: lesson from the phaeochromocytoma-paraganglioma syndromes. J Intern Med 266(1):19-42
26. Baysal BE (2002) Hereditary paraganglioma targets diverse paraganglia. J Med Genet 39(9):617-622
27. Heutink P et al (1992) A gene subject to genomic imprinting and responsible for hereditary paragangliomas maps to chromosome 11q23-qter. Hum Mol Genet 1(1):7-10
28. Mariman EC et al (1995) Fine mapping of a putatively imprinted gene for familial nonchromaffin paragangliomas to chromosome 11q13.1: evidence for genetic heterogeneity. Hum Genet 95(1):56-62
29. Niemann S et al (2001) Assignment of PGL3 to chromosome 1 (q21-q23) in a family with autosomal dominant non-chromaffin paraganglioma. Am J Med Genet 98(1):32-36
30. Welander J, Soderkvist P, Gimm O (2011) Genetics and clinical characteristics of hereditary pheochromocytomas and paragangliomas. Endocr Relat Cancer 18(6): R253-R276
31. Bardella C, Pollard PJ, Tomlinson I (2011) SDH mutations in cancer. Biochim Biophys Acta 1807(11):1432-1443
32. Muller U (2011) Pathological mechanisms and parent-of-origin effects in hereditary paraganglioma/ pheochromocytoma (PGL/PCC). Neurogenetics 12(3):175-181
33. Baysal BE et al (2000) Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science 287(5454):848-851
34. Niemann S, Muller U (2000) Mutations in SDHC cause autosomal dominant paraganglioma, type 3. Nat Genet 26(3):268-270
35. Astuti D et al (2001) Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma.Am J Hum Genet 69(1):49-54
36. Burnichon N et al (2010) SDHA is a tumor suppressor gene causing paraganglioma. Hum Mol Genet 19(15):3011-3020
37. SemenzaGL(2004) Hydroxylation of HIF-1: oxygen sensing at the molecular level. Physiology (Bethesda) 19:176-182
38. Smith TG, Robbins PA, Ratcliffe PJ (2008) The human side of hypoxia-inducible factor. Br J Haematol 141(3):325-334
39. Baysal BE, MyersEN(2002) Etiopathogenesis and clinical presentation of carotid body tumors. Microsc Res Tech 59(3):256-261
40. KingA, Selak MA, Gottlieb E (2006) Succinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer. Oncogene 25(34):4675-82
41. Fogg VC, Lanning NJ, Mackeigan JP (2011) Mitochondria in cancer: at the crossroads of life and death. Chin J Cancer 30(8):526-539
42. Wallace DC (2005) A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu Rev Genet 39:359-407
43. Gottlieb E, Tomlinson IP (2005) Mitochondrial tumour suppressors: a genetic and biochemical update. Nat Rev Cancer 5(11):857-66
44. Lee S et al (2005) Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: developmental culling and cancer. Cancer Cell 8(2):155-167
45. Korpershoek E et al (2011) SDHA immunohistochemistry detects germline SDHA gene mutations in apparently sporadic paragangliomas and pheochromocytomas. J Clin Endocrinol Metab 96(9):E1472-E1476
46. Douwes Dekker PB et al (2003) SDHD mutations in head and neck paragangliomas result in destabilization of complex II in the mitochondrial respiratory chain with loss of enzymatic activity and abnormal mitochondrial morphology. J Pathol 201(3):480-486
47. Saldana MJ, Salem LE, Travezan R (1973) High altitude hypoxia and chemodectomas. Hum Pathol 4(2):251-263
48. Astrom K et al (2003) Altitude is a phenotypic modifier in hereditary paraganglioma type 1: evidence for an oxygen-sensing defect. Hum Genet 113(3):228-237
49. AstutiDet al (2011) Mutation analysis of HIF prolyl hydroxylases (PHD/EGLN) in individuals with features of phaeochromocytoma and renal cell carcinoma susceptibility. Endocr Relat Cancer 18(1):73-83
50. Baysal BE (2008) Clinical and molecular progress in hereditary paraganglioma. J Med Genet 45(11):689-694
51. Cascon A et al (2004) Genetic and epigenetic profile of sporadic pheochromocytomas. J Med Genet 41(3):e30
52. Pigny P et al (2008) Paraganglioma after maternal transmission of a succinate dehydrogenase gene mutation. J Clin Endocrinol Metab 93(5):1609-1615
53. Hensen EF et al (2004) Somatic loss of maternal chromosome 11 causes parent-of-origindependent inheritance in SDHD-linked paraganglioma and phaeochromocytoma families. Oncogene 23(23):4076-4083
54. Bayley JP, Devilee P, Taschner PE (2005) The SDH mutation database: an online resource for succinate dehydrogenase sequence variants involved in pheochromocytoma, paraganglioma and mitochondrial complex II deficiency. BMC Med Genet 6:39